Evidence map›Paper›PMID 26669616›Full record

ArticleGut2016

The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem.

Elodie Quévrain, Marie-Anne Maubert, Harry Sokol, Bart Devreese, Philippe Seksik

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Gut, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Frontiers in microbiology · 2019
    Article
  10. Review
  11. Article
  12. Review
  13. Microbial Anti-Inflammatory Molecule (MAM) fromFrontiers in microbiology · 2017
    Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Elodie QuévrainSorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.
Marie-Anne MaubertSorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France Département PM2 Plateforme de Métabolomique, APHP, Hôpital Saint Antoine, Peptidomique et dosage de Médicaments, Paris, France.
Harry SokolService de Gastroentérologie et nutrition, APHP, Hôpital Saint Antoine, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.
Bart DevreeseDepartment of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
Philippe SeksikService de Gastroentérologie et nutrition, APHP, Hôpital Saint Antoine, Paris, France Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBacterial ProteinsCrohn DiseaseDysbiosisEubacterialesHumansIntestinal MucosaMaleBacterial ProteinsINFLAMMATORY BOWEL DISEASEINTESTINAL BACTERIA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.